AGN — Argenica Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$14.13m
- AU$9.09m
- AU$0.51m
Australia Stock Exchange release from ARGENICA THERAPE : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from ARGENICA THERAPE : Application for quotation of securities - AGN
Australia Stock Exchange release from ARGENICA THERAPE : Release of Restricted Securities from Escrow
Australia's Argenica Therapeutics climbs on Linear Clinical tie-up
Brief: Argenica Therapeutics Partners With Linear Clinical Research For Phase 1 Clinical Trial
Australia Stock Exchange release from ARGENICA THERAPE : Argenica Partners With Linear For Phase 1 Clinical Trial
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 10:03:50
Australia Stock Exchange release from ARGENICA THERAPE : Date of AGM & Closing Date for Director Nominations
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 09:17:47
Australia Stock Exchange release from ARGENICA THERAPE : Argenica Achieves Manufacturing Milestones
Australia Stock Exchange release from ARGENICA THERAPE : Appendix 4G & Corporate Governance Statement
Australia Stock Exchange release from ARGENICA THERAPE : Appendix 4E & Annual Report 30 June 2021
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:15:43
Australia Stock Exchange release from ARGENICA THERAPE : Appendix 3G
Australia Stock Exchange release from ARGENICA THERAPE : Study Additional Information
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 10:49:09
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 09:56:06
Australia Stock Exchange release from ARGENICA THERAPE : Study Shows ARG-007 Does Not Degrade
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 09:57:02